Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
X-linked Charcot-Marie-Tooth disease type 6 (CMTX6) patients with a p.R158H mutation in the pyruvate dehydrogenase kinase isoenzyme 3 gene.
Menopause in multiple sclerosis: therapeutic considerations.
SIRT1 Activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease.
Vitamin D and multiple sclerosis: Potential pathophysiological role and clinical implications.
The progress of cognitive decline in newly diagnosed MS patients.
The role of optical coherence tomography (OCT) in optic neuritis (ON).
Retinal layer segmentation of macular OCT images using boundary classification.
Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta.
Putative association of GPC5 polymorphism with the risk of inflammatory demyelinating diseases.
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.
Cognitive impairment differs between neuromyelitis optica spectrum disorder and multiple sclerosis.
Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
The Prognostic Utility of MRI in Clinically Isolated Syndrome: A Literature Review.
Novartis: CHMP Issues Positive Opinion To Expand EU Label For Gilenya In RRMS
Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis.
Jitter of corticospinal neurons during repetitive transcranial magnetic stimulation. Method and possible clinical implications.
[New aspects in the therapy of multiple sclerosis and optic neuritis.]
Biological monitoring of IFN-β therapy in Multiple Sclerosis.
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Improving communication with multiple sclerosis patients.
A rare case of multiple sclerosis and McArdle disease.
Specific Depletion of Myelin-Reactive B Cells via BCR-Targeting.
STAT4 controls GM-CSF production by both Th1 and Th17 cells during EAE.
[Demyelinating process in systematic rheumatoid diseases (review)].

Pages